|Last Price$93.42||Day Change (%)-0.45%|
|Open Price$94.20||Day Change ($)-0.42|
|Day Range93.39–94.45||52-Week Range81.37–113.65|
As of Wed 7/27/2016 10:32:00 AM | USD
Ladies and gentlemen, thank you for standing by. Welcome to the CVS Caremark Q1 2014 Earnings Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. As a reminder, this conference is being recorded Friday, ...
New Study Finds Nearly Half of People with Infertility Do Not Get Help
UPDATE: These 3 charts show the beginning of the end for Wall Street's big winners
CVS Agrees to $3.5 Million Settlement Linked to Fake Prescriptions -- Update
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.
Pharmacy benefit managers aren't household names, but recent consolidation in the industry is proving out the power of scale for these firms, says Morningstar's Matt Coffina.
We believe its acquisition strategy puts the PBM on the right course.
The wide-moat pharmacy benefit manager is still undervalued.
On Sunday, Caremark RX CMX announced that its board unanimously rejected Express Scripts' ESRX bid for the company and will continue to pursue the merger with CVS CVS . We are not changing our fair value estimates as a result of this announcement, since our estimates for all firms assume that CVS ...